Fc gamma receptor activation during viral infections: a double-edged sword

C.E. Credits: P.A.C.E. CE Florida CE
Speaker
  • Assistant Professor, Division of Infectious Diseases, Ichan School of Medicine at Mount Sinai, Co-Founder and CEO, Ichor Biologics
    Biography

      Dr. Alvarez is an Assistant Professor, in the division of Infectious Diseases at the Ichan School of Medicine at Mount Sinai, where his work focuses on the antibody-mediated mechanisms that correlate with HIV-1 suppression in HIV-1 controller patients. Dr. Alvarez has over 20 years experience conducting translational research in the infectious disease space. He is also the co-founder and CEO of Ichor Biologics, a pre-clinical biotechnology start-up that is dedicated to accelerating therapeutics in the infectious disease space.  Dr. Alvarez received his BSc. in Molecular Biology & Biochemistry from Boston University, an MSc. in the Immunology of Infectious Disease from the London School of Hygiene and Tropical Medicine and a PhD from King's College London in Molecular Virology. 


    Abstract

    Over the last several decades, antibodies (Abs) have become a valuable weapon in the fight against viral infections, with several studies demonstrating the importance of both neutralizing and non-neutralizing Ab responses in preventing or controlling viral infections in-vivo. Fc receptor mediated non-neutralizing effector functions such as, Ab-dependent Cellular Cytotoxicity (ADCC), phagocytosis and cytokine expression, have all been shown to contribute to effective immune responses in-vivo. However, in the case of some viral infections, such as dengue, Ab/Fc receptor mediated interactions enhance the severity of dengue hemorrhagic fever via Antibody Dependent Enhancement (ADE), which is hypothesized to primarily occur via Fc gamma receptor (FcγR) interactions. Importantly, in the context of the current SARS CoV-2 pandemic, researchers have observed that disease severity correlates with anti-SARS CoV-2 spike protein levels. Further, previous studies on a SARS1 vaccine suggest that ADE may contribute to mortality in animal models. These findings have important implications for anti-spike based SARS CoV-2 therapeutics and vaccine approaches. Therefore, our laboratory has begun to profile the levels of FcγR activation in a cohort of SARS CoV-2 convalescent patients versus severe hospitalized patients, to begin to understand whether ADE is a primary driver of severity and mortality during COVID-19 disease.

    Learning objectives:

    1. To learn how non-neutralizing Ab responses contribute to immune regulation during viral infections

    2. To learn how in the majority of viral infections, non-neutralizing antibodies help to potently control infections in-vivo

    3. To learn that in the context of certain viral infections, such as dengue, non-neutralizing Ab functions can be detrimental to the host and enhance severity of disease


    Show Resources
    You May Also Like
    SEP 10, 2020 9:00 AM PDT
    C.E. CREDITS
    SEP 10, 2020 9:00 AM PDT
    Date: September 10, 2020 Time: 9:00am (PDT), 12:00pm (EDT) Osmolality testing is relevant throughout the entire bioprocessing workflow. As customers look to refine mAb and gene therapy workf...
    DEC 02, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    C.E. CREDITS
    DEC 02, 2020 8:00 AM PST
    Add to Calendar Select one of the following: iCal Google Calendar Outlook Calendar Yahoo Calendar
    DATE: December 2nd, 2020 TIME: 08:00am PDT, 11:00pm EDT Bioreactors and shakers are used to cultivate microorganisms, plant, insect, and mammalian cells in different volumes. Upscaling of pr...
    OCT 08, 2020 7:00 AM PDT
    C.E. CREDITS
    OCT 08, 2020 7:00 AM PDT
    DATE: October 8, 2020 TIME: 7:00am PDT, 10:00am EDT, 4:00pm CEST How often do you pipette in your cell culture lab every day? Usually, we do it so often that we tend stop thinking about ho...
    JUL 22, 2020 10:00 AM PDT
    C.E. CREDITS
    JUL 22, 2020 10:00 AM PDT
    DATE: July 23, 2020 TIME: 10:00 am PDT The SARS-CoV-2 pandemic has taken a toll on many sectors of the medical community. As the pandemic took a grip on the laboratory, the need for diagnost...
    JUN 09, 2020 10:00 AM PDT
    C.E. CREDITS
    JUN 09, 2020 10:00 AM PDT
    DATE: June 9, 2020 TIME: 10:00am PT, 1:00pm ET The presentation will first discuss sepsis as a disease and then explain the importance of performing diagnostic tests in the clinical labora...
    AUG 25, 2020 8:00 AM PDT
    C.E. CREDITS
    AUG 25, 2020 8:00 AM PDT
    DATE: August 25, 2020 TIME: 8:00am PDT, 10:00am CDT, 11:00am EDT Recombinant lentivirus (LV) and adeno-associated virus (AAV) are critical components of cell and gene therapies, which show g...
    Loading Comments...
    Show Resources